Minimal change disease (minimal change nephropathy; lipoid nephrosis)
Bedside summary
Commonest cause of nephrotic syndrome in children (~90% under 10 years) and a significant cause in adults. Light microscopy is normal; electron microscopy shows diffuse podocyte foot-process effacement with no immune deposits. Typically abrupt-onset nephrotic syndrome with selective proteinuria and preserved GFR. Highly steroid-responsive. May be idiopathic or secondary (NSAIDs, lithium, Hodgkin lymphoma, atopy). Key tasks: induce remission with corticosteroids and manage nephrotic complications (oedema, thrombosis, infection).
Red flags
- AKI (intravascular depletion/overdiuresis, acute tubular injury, or interstitial nephritis) complicating minimal change
- Thromboembolism (DVT/PE/renal vein thrombosis) with severe hypoalbuminaemia
- Sepsis/peritonitis (pneumococcal) — functional immunosuppression
- Steroid resistance (no remission after adequate course) — reconsider FSGS, re-biopsy
- New minimal change in an adult — exclude Hodgkin lymphoma and offending drugs
Assessment
Differential diagnosis
- FSGS (may be indistinguishable clinically; more haematuria/hypertension/impaired GFR, steroid-resistant)
- Membranous nephropathy (older adults, anti-PLA2R)
- Diabetic nephropathy; amyloid/myeloma
- Secondary minimal change: NSAIDs, lithium, Hodgkin lymphoma, allergy
- IgA nephropathy with overlapping minimal-change lesion
Investigations
- Urine PCR/ACR + microscopy (bland, selective proteinuria; minimal haematuria)
- Serum albumin, U&E/creatinine/eGFR, lipids
- Exclude secondary causes: drug history (NSAIDs/lithium), consider lymphoma screen in adults; HBV/HCV/HIV
- Immunology (ANA, complement, anti-PLA2R) to exclude other causes in adults
- Renal biopsy in adults (children with typical presentation are treated empirically with steroids without biopsy); EM shows foot-process effacement
Management
- In a child with typical nephrotic syndrome, treat empirically with corticosteroids without biopsy; biopsy adults and atypical/steroid-resistant children
- Induce remission with high-dose corticosteroids (most remit within 2-4 weeks; adults may take longer up to 8-16 weeks)
- Supportive nephrotic care: sodium restriction + loop diuretic for oedema, statin, VTE risk assessment/prophylaxis if albumin very low, infection vigilance
- On remission, taper steroids slowly over months to reduce relapse
- For frequent relapses or steroid dependence/toxicity, use steroid-sparing agents (calcineurin inhibitor, cyclophosphamide, MMF or rituximab) via nephrology
- Identify and remove secondary triggers (stop NSAIDs/lithium; treat underlying lymphoma)
- Monitor for relapse (teach home urine dipstick in children) and steroid side effects
Drugs & doses
Disposition
Complications & pitfalls
- Relapsing/steroid-dependent course; steroid toxicity
- Venous thromboembolism and infection (as for any nephrotic syndrome)
- AKI (especially adults)
- Hyperlipidaemia
- Rarely progression to FSGS/CKD
Exam pearls
- Minimal change is the great steroid-responder: most children remit within 2-4 weeks; adults respond too but more slowly (allow up to ~16 weeks before calling steroid resistance).
- Children with typical nephrotic syndrome are treated with steroids WITHOUT biopsy; biopsy adults and steroid-resistant/atypical children.
- A secondary cause (NSAIDs, lithium, Hodgkin lymphoma) should be sought in adults — remission may follow trigger removal/treatment.
- Frequently relapsing or steroid-dependent disease is where rituximab and calcineurin inhibitors earn their place as steroid-sparing agents.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.